Neonatal Hypoglycemia Clinical Trial
Official title:
Continuous Glucose Monitoring in At-Risk Newborns: A Feasibility Study
Hypoglycemia (low blood glucose) is a very common problem in newborns, and has been associated with poor neurodevelopment, cognition, and school performance. At-risk newborns (infants of diabetic mothers [IDM], large [LGA] and small [SGA] for gestational age infants, and late preterm [LPT] infants) undergo a hypoglycemia screening protocol that involves numerous intermittent needle sticks to test glucose levels on bedside glucometers; however, continuous glucose monitoring (CGM, currently not approved for clinical use in babies), via a small sensor placed in the thigh (only 1 needle stick), would likely decrease pain while providing continuous glucose levels. This study will evaluate the feasibility, safety, and precision of CGM in at-risk newborns, and determine if this method would decrease the amount of painful procedures and episodes of hypoglycemia missed by intermittent sampling. As part of regular medical care, participants will undergo intermittent blood glucose screening with heel sticks as per the current hospital standard of care protocol. Regular medical care involves checking the participant's blood glucose via heel stick every few hours using a bedside glucometer, with another heel stick to confirm low values in the laboratory. If the participant has low values, he/she may be treated with oral glucose gel, feedings of breast milk or formula, or intravenous (IV) fluids in the Neonatal Intensive Care Unit (NICU). This research study involves placing a CGM device in addition to undergoing the current blood glucose screening protocol and treatment. As soon as possible after birth, a continuous glucose monitoring device (Dexcom G7) will be placed on the participant's thigh by a research team member, and will blindly continuously record glucose levels that will be analyzed after discharge. Everyone who agrees to participate in this study will have placement of this experimental device. The investigational device will stay in place for the same amount of time that a participant is undergoing blood glucose monitoring as per the current standard of care protocol, for a maximum of 7 days. A participant may need to have his/her blood glucose checked after 7 days for regular medical care (and not for research), because his/her glucose concentrations are still low. Being in the research study will not affect a participant's medical care, and will not affect how long he/she needs blood glucose monitoring or treatment. A research team member will place and remove the CGM. Nurses will evaluate the site of the device for signs of irritation, infection, bleeding, and any other issues at least 3 times per day. After discharge from the hospital, data will be collected from the participant's medical record and participant's mother's medical record, including the participant's sex and birth weight, blood glucose values, details of feedings, treatments given for low glucose concentrations, and NICU admission data. Data that will be collected from the participant's mother's medical record includes age and race, prenatal data, medical history, and medication use. The participant's parents will be asked to fill out a short survey about their experience with this device when it is removed.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02583776 -
Continuous Glucose Monitoring and Preterm Infants
|
Phase 4 | |
Not yet recruiting |
NCT05977972 -
Pattern of Metabolic Causes of Neonatal Hypoglycemia
|
||
Recruiting |
NCT04458649 -
Continuous Glucose Monitoring in Infants
|
||
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Completed |
NCT03032523 -
Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)
|
N/A | |
Completed |
NCT03726697 -
Effect of Tahneek on Hypoglycemia in Newborn Infants
|
N/A | |
Terminated |
NCT04085978 -
Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission
|
||
Terminated |
NCT05647798 -
Intrapartum Glycemic Control in GDMA2
|
N/A | |
Not yet recruiting |
NCT04811612 -
Comparing Heel Stick Glucoses in Neonates
|
N/A | |
Not yet recruiting |
NCT02648555 -
A Lifestyle Intervention to Improve in Vitro Fertilization Results
|
N/A | |
Recruiting |
NCT06373432 -
Frequency of Glucose Monitoring in Labor
|
N/A | |
Completed |
NCT04030312 -
Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant
|
N/A | |
Completed |
NCT03076775 -
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
|
N/A | |
Completed |
NCT05022433 -
Comparison of the Shukla and UN-1 Formulae in the Placement of the Umbilical Venous Catheter Among Neonates
|
||
Recruiting |
NCT00332449 -
Early Breast Feeding and Glucose Levels in High Risk Newborns
|
N/A | |
Not yet recruiting |
NCT04869709 -
Late Preterm Corticosteroids and Neonatal Hypoglycemia
|
Phase 4 | |
Completed |
NCT02523222 -
Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia
|
N/A | |
Recruiting |
NCT04875624 -
Neurodevelopment of Hypoglycemic Neonates
|
||
Completed |
NCT02605369 -
SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan
|
N/A | |
Withdrawn |
NCT03738293 -
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids
|